Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFN-α studies find that individuals who develop major depressive disorder during the course of treatment exhibit higher inflammatory reactivity [20–24], greater glucocorticoid reactivity [25, 26], and higher levels of pre-treatment neuroticism, depression and sleep disturbance (and trend towards increased anxiety) [27–29]”
From Moderators of inflammation-related depression: a prospective study of breast cancer survivors (2021) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Self-citationInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Self-citationGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“Our findings of decreased post-DEX suppression of cortisol along with flattened cortisol slope in patients with hepatitis C virus administered IFN-alpha is similar to that which has been observed in patients with metastatic breast cancer [58], and in patients with major depression [26,39].”
ResultSelf-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 1×
“However, IFN-alpha monotherapy for malignant melanoma has been associated with profound induction of depression and fatigue [6,34,48], indicating that treatment effects on behavior in this study were likely attributable to specific effects of IFN-alpha.”
BackgroundSelf-citationDiurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
Sephton, S. E. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.994 · Cited by 1,082
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Self-citationMiller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Self-citationSocial regulation of gene expression in human leukocytes
Cole, S. W., Hawkley, L. C., Arevalo, J. M., Sung, C. Y., Rose, R. M., & Cacioppo, J. T. (2007) · Genome Biology · doi:10.1186/gb-2007-8-9-r189 · Cited by 745 · cited 1×
“well as other populations experiencing significant psychosocial stress [5,8,31].”
Background
Research works printed but not linked: 33
- Abercrombie, 2004, Flattened cortisol rhythms in metastatic breast cancer patients, Psychoneuroendocrinology, 29, 1082, 10.1016/j.psyneuen.2003.11.003 · DOI · Paper page
- Asnis, 2004, Ribavirin may be an important factor in IFN-induced neuropsychiatric effects, J. Clin. Psychiatry, 65, 581, 10.4088/JCP.v65n0420b · DOI
- Bower, 2002, Fatigue and proinflammatory cytokine activity in breast cancer survivors, Psychosom. Med., 64, 604, 10.1097/00006842-200207000-00010 · DOI · Paper page
- Bower, 2005, Diurnal cortisol rhythm and fatigue in breast cancer survivors, Psychoneuroendocrinology, 30, 92, 10.1016/j.psyneuen.2004.06.003 · DOI · Paper page
- Bower, 2011, Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue, Brain Behav. Immun., 25, 147, 10.1016/j.bbi.2010.09.010 · DOI · Paper page
- Champaneri, 2013, Diurnal salivary cortisol is associated with body mass index and waist circumference: the Multiethnic Study of Atherosclerosis, Obesity, 21, E56, 10.1002/oby.20047 · DOI · Paper page
- Dallman, 2007, Glucocorticoids, the etiology of obesity and the metabolic syndrome, Curr. Alzheimer Res., 4, 199, 10.2174/156720507780362236 · DOI · Paper page
- Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol. Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
- Engler, 2008, Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen, Psychoneuroendocrinology, 33, 108, 10.1016/j.psyneuen.2007.10.007 · DOI · Paper page
- Evans, 2005, Mood disorders in the medically ill: scientific review and recommendations, Biol. Psychiatry, 58, 175, 10.1016/j.biopsych.2005.05.001 · DOI · Paper page
- Felger, 2012, Molecular signatures of peripheral blood mononuclear cells during chronic interferon-alpha treatment: relationship with depression and fatigue, Psychol. Med., 42, 1591, 10.1017/S0033291711002868 · DOI · Paper page
- Felger, 2015, Molecular signatures of peripheral blood mononuclear cells during chronic interferon-alpha treatment: relationship with depression and fatigue, Psychol. Med., 1
- Giese-Davis, 2004, Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer, Health Psychol., 23, 645, 10.1037/0278-6133.23.6.645 · DOI
- Heim, 2009, Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene, Front. Behav. Neurosci., 3, 41, 10.3389/neuro.08.041.2009 · DOI · Paper page
- Heim, 2008, The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma, Biol. Psychiatry, 63, 398, 10.1016/j.biopsych.2007.07.002 · DOI · Paper page
- Hu, 2009, Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells, Brain Behav. Immun., 23, 455, 10.1016/j.bbi.2009.01.001 · DOI · Paper page
- Hubain, 1998, The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis, Biol. Psychiatry, 43, 220, 10.1016/S0006-3223(97)80434-9 · DOI
- Judd, 1995, Differential release of tumor necrosis factor and IL-6 from adrenal zona glomerulosa cells in vitro, Am. J. Physiol., 268, E114
- Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
- Musselman, 2001, Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings, Am. J. Psychiatry, 158, 1252, 10.1176/appi.ajp.158.8.1252 · DOI · Paper page
- Pace, 2011, Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha, Brain Behav. Immun., 25, 1716, 10.1016/j.bbi.2011.07.227 · DOI · Paper page
- Raison, 2008, Interferon-alpha effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior, Mol. Psychiatry
- Raison, 2010, Interferon-alpha effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behavior, Mol. Psychiatry, 15, 535, 10.1038/mp.2008.58 · DOI · Paper page
- Raison, 2006, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol., 27, 24, 10.1016/j.it.2005.11.006 · DOI · Paper page
- Rosmond, 2000, The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke, J. Intern. Med., 247, 188, 10.1046/j.1365-2796.2000.00603.x · DOI · Paper page
- Schrepf, 2015, Diurnal cortisol and survival in epithelial ovarian cancer, Psychoneuroendocrinology, 53, 256, 10.1016/j.psyneuen.2015.01.010 · DOI · Paper page
- Slavich, 2015, Understanding inflammation, its regulation, and relevance for health: a top scientific and public priority, Brain Behav. Immun., 45, 13, 10.1016/j.bbi.2014.10.012 · DOI · Paper page
- Smets, 1995, The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue, J. Psychosom. Res., 39, 315, 10.1016/0022-3999(94)00125-O · DOI · Paper page
- Spiegel, 2006, Stress sensitivity in metastatic breast cancer: analysis of hypothalamic–pituitary–adrenal axis function, Psychoneuroendocrinology, 31, 1231, 10.1016/j.psyneuen.2006.09.004 · DOI
- Ticher, 1996, The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk, Int. J. Cancer, 65, 591, 10.1002/(SICI)1097-0215(19960301)65:5<591::AID-IJC6>3.0.CO;2-Y · DOI · Paper page
- Torres, 2013, Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B, Cancer, 119, 1951, 10.1002/cncr.28003 · DOI · Paper page
- Vegiopoulos, 2007, Glucocorticoids, metabolism and metabolic diseases, Mol. Cell. Endocrinol., 275, 43, 10.1016/j.mce.2007.05.015 · DOI · Paper page
- Zunszain, 2013, Inflammation and depression, Curr. Top. Behav. Neurosci., 14, 135, 10.1007/7854_2012_211 · DOI · Paper page
Cited by
The Role of Inflammation in Depression and Fatigue
Lee, C.-H., & Giuliani, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01696 · Cited by 640
Immune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
Depression, dementia and immune dysregulation
Hayley, S., Hakim, A. M., & Albert, P. R. (2021) · Brain · doi:10.1093/brain/awaa405 · Cited by 186
Moderators of inflammation-related depression: a prospective study of breast cancer survivors
Manigault, A. W., Ganz, P. A., Irwin, M. R., Cole, S. W., Kuhlman, K. R., & Bower, J. E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01744-6 · Cited by 29
Metadata
- Authors
- Felger, J. C., Haroon, E., Woolwine, B. J., Raison, C. L., & Miller, A. H.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 166
- Pages
- 14-21
- ISSN
- 0031-9384
- Cited by
- 42
- References
- 31
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institutes of Health (K23 MH064619, R01 MH070553, K05MH069124, R01HL073921, R01MH075102, T32 MH020018)
- Emory Center for AIDS Research (P30 AI050409)
- Clinical and Translational Science Award Program (UL1 RR025008)
- General Clinical Research Center Program, National Institutes of Health, National Center for Research Resources (M01 RR0039)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus. https://app.cochat.ai/papers/10.1016/j.physbeh.2015.12.013
- The paper
- Felger, J. C., Haroon, E., Woolwine, B. J., Raison, C. L., & Miller, A. H. (2016). Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus. Physiology & Behavior. https://doi.org/10.1016/j.physbeh.2015.12.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.